{"transactions":[{"id":914311,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-09T16:40:38.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). \"Vesting Commencement Date\" shall mean February 5, 2026."}],"balance_after":17500,"derivative":{"exercise_price":16,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001427569-26-000008","document":"form4-02092026_090235.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000142756926000008/form4-02092026_090235.xml","form_type":"4"}},{"id":1545429,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-08T16:14:37.000Z","date":"2024-04-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":450000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, Atlas Neon Parent, Inc. (\"Parent\") and Atlas Neon Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Purchaser\"), dated as of February 25, 2024 (\"Merger Agreement\"), pursuant to which the Purchaser completed a tender offer for the shares of common stock of the Issuer and thereafter merged with and into the Issuer effective as of April 5, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement and Purchaser's offer to purchase, the shares of common stock were tendered to Purchaser in consideration for a per share price of $1.55 in cash, subject to applicable tax withholding and without interest (the \"Offer Price\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the Merger Agreement, as of the Effective Time, the vesting of each outstanding unvested Stock Option that had a per share exercise price that was less than the Offer Price (an \"In-the-Money Option\") was accelerated and each outstanding In-the-Money Option (both vested and unvested) was canceled and the holder of such canceled Stock Option was entitled to receive an amount in cash, without interest and less any withholding of taxes, equal to the product of (i) the excess of the Offer Price over the applicable exercise price per share subject to such Stock Option multiplied by (ii) the total number of shares subject to such Stock Option. Each Stock Option that was not an In-the-Money Option (whether vested or unvested) was canceled as of the Effective Time for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, Atlas Neon Parent, Inc. (\"Parent\") and Atlas Neon Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Purchaser\"), dated as of February 25, 2024 (\"Merger Agreement\"), pursuant to which the Purchaser completed a tender offer for the shares of common stock of the Issuer and thereafter merged with and into the Issuer effective as of April 5, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement and Purchaser's offer to purchase, the shares of common stock were tendered to Purchaser in consideration for a per share price of $1.55 in cash, subject to applicable tax withholding and without interest (the \"Offer Price\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, as of the Effective Time, the vesting of each outstanding unvested Stock Option that had a per share exercise price that was less than the Offer Price (an \"In-the-Money Option\") was accelerated and each outstanding In-the-Money Option (both vested and unvested) was canceled and the holder of such canceled Stock Option was entitled to receive an amount in cash, without interest and less any withholding of taxes, equal to the product of (i) the excess of the Offer Price over the applicable exercise price per share subject to such Stock Option multiplied by (ii) the total number of shares subject to such Stock Option. Each Stock Option that was not an In-the-Money Option (whether vested or unvested) was canceled as of the Effective Time for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, as of the Effective Time, the vesting of each outstanding unvested Stock Option that had a per share exercise price that was less than the Offer Price (an \"In-the-Money Option\") was accelerated and each outstanding In-the-Money Option (both vested and unvested) was canceled and the holder of such canceled Stock Option was entitled to receive an amount in cash, without interest and less any withholding of taxes, equal to the product of (i) the excess of the Offer Price over the applicable exercise price per share subject to such Stock Option multiplied by (ii) the total number of shares subject to such Stock Option. Each Stock Option that was not an In-the-Money Option (whether vested or unvested) was canceled as of the Effective Time for no consideration."}],"balance_after":0,"derivative":{"exercise_price":0.77,"expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0000950170-24-042611","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000095017024042611/ownership.xml","form_type":"4"}},{"id":1545428,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-04-08T16:14:37.000Z","date":"2024-04-05","kind":"other","planned":false,"acquired":false,"shares":3038,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 3,000 shares acquired under the Issuer's Employee Stock Purchase Plan on March 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger entered into by and among the Issuer, Atlas Neon Parent, Inc. (\"Parent\") and Atlas Neon Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Purchaser\"), dated as of February 25, 2024 (\"Merger Agreement\"), pursuant to which the Purchaser completed a tender offer for the shares of common stock of the Issuer and thereafter merged with and into the Issuer effective as of April 5, 2024 (the \"Effective Time\"). Pursuant to the terms of the Merger Agreement and Purchaser's offer to purchase, the shares of common stock were tendered to Purchaser in consideration for a per share price of $1.55 in cash, subject to applicable tax withholding and without interest (the \"Offer Price\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-042611","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000095017024042611/ownership.xml","form_type":"4"}},{"id":1723719,"issuer":{"id":11997,"kind":"organization","name":"NGM BIOPHARMACEUTICALS INC","symbol":"NGM"},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-04T16:27:06.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest over a four-year period commencing November 3, 2023, with 1/4th of the shares vesting on November 3, 2024 and 1/48th of the shares vesting monthly thereafter."}],"balance_after":450000,"derivative":{"exercise_price":0.77,"expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-23-057214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000120919123057214/doc4.xml","form_type":"4"}},{"id":2881486,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T17:37:27.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":7402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":54167,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":7402},"source":{"system":"sec-edgar","filing":"0001567619-21-002141","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921002141/doc1.xml","form_type":"4"}},{"id":2881485,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T17:37:27.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":7402,"price":21.55,"value":159513.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 restricted stock units."}],"balance_after":61295,"source":{"system":"sec-edgar","filing":"0001567619-21-002141","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921002141/doc1.xml","form_type":"4"}},{"id":2881484,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-03T17:37:27.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":7402,"price":10.05,"value":74390.1,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 restricted stock units."}],"balance_after":68697,"source":{"system":"sec-edgar","filing":"0001567619-21-002141","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921002141/doc1.xml","form_type":"4"}},{"id":2893392,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-27T16:15:38.000Z","date":"2021-01-25","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":61569,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001567619-21-001600","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921001600/doc1.xml","form_type":"4"}},{"id":2893391,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-27T16:15:38.000Z","date":"2021-01-25","kind":"sale","acquired":false,"shares":6144,"price":19,"value":116736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 restricted stock units."}],"balance_after":61295,"source":{"system":"sec-edgar","filing":"0001567619-21-001600","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921001600/doc1.xml","form_type":"4"}},{"id":2893390,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-27T16:15:38.000Z","date":"2021-01-25","kind":"sale","acquired":false,"shares":40000,"price":20.1,"value":804000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 restricted stock units."}],"balance_after":67439,"source":{"system":"sec-edgar","filing":"0001567619-21-001600","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921001600/doc1.xml","form_type":"4"}},{"id":2893389,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-27T16:15:38.000Z","date":"2021-01-25","kind":"exercise","acquired":true,"shares":40000,"price":10.05,"value":402000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 restricted stock units."}],"balance_after":107439,"source":{"system":"sec-edgar","filing":"0001567619-21-001600","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921001600/doc1.xml","form_type":"4"}},{"id":2908139,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-13T16:23:21.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":17.58,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-21-000982","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921000982/doc1.xml","form_type":"4"}},{"id":2908138,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-13T16:23:21.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 11 of each year, with the first 1/3 vesting on January 11, 2022 and with the RSUs being fully vested on January 11, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 52,083 RSUs."}],"balance_after":67439,"source":{"system":"sec-edgar","filing":"0001567619-21-000982","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921000982/doc1.xml","form_type":"4"}},{"id":2909507,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-12T16:55:02.000Z","date":"2021-01-10","kind":"tax_withholding","acquired":false,"shares":4080,"price":18.18,"value":74174.4,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20,833 restricted stock units."}],"balance_after":36189,"source":{"system":"sec-edgar","filing":"0001567619-21-000922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761921000922/doc1.xml","form_type":"4"}},{"id":2972996,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-19T16:16:19.000Z","date":"2020-11-17","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"All of the shares underlying this option are vested and exercisable as of the date hereof."}],"balance_after":110241,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001567619-20-020095","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920020095/doc1.xml","form_type":"4"}},{"id":2972995,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-11-19T16:16:19.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":1500,"price":13.5,"value":20250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 31,250 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 341 shares acquired on November 13, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":40269,"source":{"system":"sec-edgar","filing":"0001567619-20-020095","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920020095/doc1.xml","form_type":"4"}},{"id":2972994,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-11-19T16:16:19.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":1995,"price":17.4919,"value":34896.3405,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $17.27 to $17.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 31,250 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 341 shares acquired on November 13, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":38769,"source":{"system":"sec-edgar","filing":"0001567619-20-020095","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920020095/doc1.xml","form_type":"4"}},{"id":3005094,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-10-16T16:19:40.000Z","date":"2020-10-14","kind":"sale","acquired":false,"shares":6144,"price":19,"value":116736.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 restricted stock units."}],"balance_after":40423,"source":{"system":"sec-edgar","filing":"0001567619-20-017922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920017922/doc1.xml","form_type":"4"}},{"id":3137036,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-05-22T16:30:26.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":1278,"price":17.66,"value":22569.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,004 shares acquired on May 15, 2020, pursuant to Issuer's employee stock purchase plan."}],"balance_after":46567,"source":{"system":"sec-edgar","filing":"0001567619-20-011016","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920011016/doc1.xml","form_type":"4"}},{"id":3256321,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-21T18:16:35.000Z","date":"2020-02-19","kind":"exercise","acquired":false,"shares":3159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":101569,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":3159},"source":{"system":"sec-edgar","filing":"0001567619-20-004636","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920004636/doc1.xml","form_type":"4"}},{"id":3256320,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-21T18:16:35.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":3159,"price":22.3336,"value":70551.8424,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $22.09 to $22.73, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":46841,"source":{"system":"sec-edgar","filing":"0001567619-20-004636","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920004636/doc1.xml","form_type":"4"}},{"id":3256319,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-02-21T18:16:35.000Z","date":"2020-02-19","kind":"exercise","acquired":true,"shares":3159,"price":10.05,"value":31747.95,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001567619-20-004636","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920004636/doc1.xml","form_type":"4"}},{"id":3307731,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-17T16:11:01.000Z","date":"2020-01-15","kind":"exercise","acquired":false,"shares":6318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":104728,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":6318},"source":{"system":"sec-edgar","filing":"0001567619-20-001235","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001235/doc1.xml","form_type":"4"}},{"id":3307730,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-17T16:11:01.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":2798,"price":20.0807,"value":56185.7986,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $20.00 to $20.36, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":46841,"source":{"system":"sec-edgar","filing":"0001567619-20-001235","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001235/doc1.xml","form_type":"4"}},{"id":3307729,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-17T16:11:01.000Z","date":"2020-01-15","kind":"sale","acquired":false,"shares":3520,"price":19.6699,"value":69238.048,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $19.00 to $19.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":49639,"source":{"system":"sec-edgar","filing":"0001567619-20-001235","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001235/doc1.xml","form_type":"4"}},{"id":3307728,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-17T16:11:01.000Z","date":"2020-01-15","kind":"exercise","acquired":true,"shares":6318,"price":10.05,"value":63495.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 31,250 restricted stock units."}],"balance_after":53159,"source":{"system":"sec-edgar","filing":"0001567619-20-001235","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001235/doc1.xml","form_type":"4"}},{"id":3311544,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T17:48:58.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 10, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":62500,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001567619-20-001039","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001039/doc1.xml","form_type":"4"}},{"id":3311543,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T17:48:58.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 10 of each year, with the first 1/3 vesting on January 10, 2021 and with the RSUs being fully vested on January 10, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 31,250 RSUs."}],"balance_after":46841,"source":{"system":"sec-edgar","filing":"0001567619-20-001039","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001039/doc1.xml","form_type":"4"}},{"id":3311542,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T17:48:58.000Z","date":"2020-01-10","kind":"tax_withholding","acquired":false,"shares":7077,"price":17.73,"value":125475.21,"ownership":{"direct":true},"balance_after":15591,"source":{"system":"sec-edgar","filing":"0001567619-20-001039","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001039/doc1.xml","form_type":"4"}},{"id":3311541,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-01-14T17:48:58.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":19365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":22668,"source":{"system":"sec-edgar","filing":"0001567619-20-001039","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761920001039/doc1.xml","form_type":"4"}},{"id":3361069,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-11-22T16:09:10.000Z","date":"2019-11-20","kind":"exercise","acquired":false,"shares":3159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":111046,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":3159},"source":{"system":"sec-edgar","filing":"0001567619-19-022077","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761919022077/doc1.xml","form_type":"4"}},{"id":3361068,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-22T16:09:10.000Z","date":"2019-11-20","kind":"sale","acquired":false,"shares":3159,"price":19.5859,"value":61871.8581,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $19.085 to $19.98, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3303,"source":{"system":"sec-edgar","filing":"0001567619-19-022077","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761919022077/doc1.xml","form_type":"4"}},{"id":3361067,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-22T16:09:10.000Z","date":"2019-11-20","kind":"exercise","acquired":true,"shares":3159,"price":10.05,"value":31747.95,"ownership":{"direct":true},"balance_after":6462,"source":{"system":"sec-edgar","filing":"0001567619-19-022077","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761919022077/doc1.xml","form_type":"4"}},{"id":3364189,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-11-20T16:22:24.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":3112,"price":18.8809,"value":58757.3608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $18.74 to $19.065, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 30 shares acquired on November 15, 2019 pursuant to Issuer's employee stock purchase plan."}],"balance_after":3303,"source":{"system":"sec-edgar","filing":"0001567619-19-021956","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000156761919021956/doc1.xml","form_type":"4"}},{"id":3389710,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-10-22T16:06:09.000Z","date":"2019-10-18","kind":"sale","acquired":false,"shares":1388,"price":19.02,"value":26399.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."}],"balance_after":6385,"source":{"system":"sec-edgar","filing":"0000899243-19-025822","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319025822/doc4.xml","form_type":"4"}},{"id":3390989,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-18T16:05:49.000Z","date":"2019-10-16","kind":"exercise","acquired":false,"shares":3159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":114205,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":3159},"source":{"system":"sec-edgar","filing":"0000899243-19-025758","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319025758/doc4.xml","form_type":"4"}},{"id":3390988,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-10-18T16:05:49.000Z","date":"2019-10-16","kind":"sale","acquired":false,"shares":3159,"price":19,"value":60021.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."}],"balance_after":7773,"source":{"system":"sec-edgar","filing":"0000899243-19-025758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319025758/doc4.xml","form_type":"4"}},{"id":3390987,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-10-18T16:05:49.000Z","date":"2019-10-16","kind":"exercise","acquired":true,"shares":3159,"price":10.05,"value":31747.95,"ownership":{"direct":true},"balance_after":10932,"source":{"system":"sec-edgar","filing":"0000899243-19-025758","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319025758/doc4.xml","form_type":"4"}},{"id":3406282,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-09-25T16:05:23.000Z","date":"2019-09-23","kind":"sale","acquired":false,"shares":740,"price":21.78,"value":16117.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."}],"balance_after":7773,"source":{"system":"sec-edgar","filing":"0000899243-19-024242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319024242/doc4.xml","form_type":"4"}},{"id":3408917,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-20T16:05:24.000Z","date":"2019-09-18","kind":"exercise","acquired":false,"shares":3159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":117364,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":3159},"source":{"system":"sec-edgar","filing":"0000899243-19-023989","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319023989/doc4.xml","form_type":"4"}},{"id":3408916,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-09-20T16:05:24.000Z","date":"2019-09-18","kind":"sale","acquired":false,"shares":3159,"price":20.4368,"value":64559.8512,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $19.94 to $20.725, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8513,"source":{"system":"sec-edgar","filing":"0000899243-19-023989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319023989/doc4.xml","form_type":"4"}},{"id":3408915,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-09-20T16:05:24.000Z","date":"2019-09-18","kind":"exercise","acquired":true,"shares":3159,"price":10.05,"value":31747.95,"ownership":{"direct":true},"balance_after":11672,"source":{"system":"sec-edgar","filing":"0000899243-19-023989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319023989/doc4.xml","form_type":"4"}},{"id":3430095,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-23T16:05:40.000Z","date":"2019-08-21","kind":"exercise","acquired":false,"shares":6318,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":120523,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":6318},"source":{"system":"sec-edgar","filing":"0000899243-19-022360","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319022360/doc4.xml","form_type":"4"}},{"id":3430094,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-08-23T16:05:40.000Z","date":"2019-08-21","kind":"sale","acquired":false,"shares":6058,"price":21.7507,"value":131765.7406,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $21.35 to $22.28, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":8513,"source":{"system":"sec-edgar","filing":"0000899243-19-022360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319022360/doc4.xml","form_type":"4"}},{"id":3430093,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-08-23T16:05:40.000Z","date":"2019-08-21","kind":"sale","acquired":false,"shares":260,"price":20.7257,"value":5388.682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $20.32 to $21.32, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":14571,"source":{"system":"sec-edgar","filing":"0000899243-19-022360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319022360/doc4.xml","form_type":"4"}},{"id":3430092,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-08-23T16:05:40.000Z","date":"2019-08-21","kind":"exercise","acquired":true,"shares":6318,"price":10.05,"value":63495.9,"ownership":{"direct":true},"balance_after":14831,"source":{"system":"sec-edgar","filing":"0000899243-19-022360","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319022360/doc4.xml","form_type":"4"}},{"id":3432008,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-08-21T16:05:25.000Z","date":"2019-08-19","kind":"sale","acquired":false,"shares":3000,"price":19.04,"value":57120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person."}],"balance_after":8513,"source":{"system":"sec-edgar","filing":"0000899243-19-022200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319022200/doc4.xml","form_type":"4"}},{"id":3482369,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-20T16:05:28.000Z","date":"2019-06-19","kind":"exercise","acquired":false,"shares":3159,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":126841,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":3159},"source":{"system":"sec-edgar","filing":"0000899243-19-017621","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319017621/doc4.xml","form_type":"4"}},{"id":3482368,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-20T16:05:28.000Z","date":"2019-06-19","kind":"sale","acquired":false,"shares":100,"price":20.81,"value":2081.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."}],"balance_after":11513,"source":{"system":"sec-edgar","filing":"0000899243-19-017621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319017621/doc4.xml","form_type":"4"}},{"id":3482367,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-20T16:05:28.000Z","date":"2019-06-19","kind":"sale","acquired":false,"shares":3059,"price":20.3224,"value":62166.2216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The transaction was executed in multiple trades in prices ranging from $19.75 to $20.75, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":11613,"source":{"system":"sec-edgar","filing":"0000899243-19-017621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319017621/doc4.xml","form_type":"4"}},{"id":3482366,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-20T16:05:28.000Z","date":"2019-06-19","kind":"exercise","acquired":true,"shares":3159,"price":10.05,"value":31747.95,"ownership":{"direct":true},"balance_after":14672,"source":{"system":"sec-edgar","filing":"0000899243-19-017621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319017621/doc4.xml","form_type":"4"}},{"id":3482365,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-20T16:05:28.000Z","date":"2019-06-19","kind":"sale","acquired":false,"shares":667,"price":20,"value":13340.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."}],"balance_after":11513,"source":{"system":"sec-edgar","filing":"0000899243-19-017621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319017621/doc4.xml","form_type":"4"}},{"id":3482364,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-20T16:05:28.000Z","date":"2019-06-18","kind":"sale","acquired":false,"shares":3000,"price":19.3088,"value":57926.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to one or more Rule 10b5-1 trading plans adopted by Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $19.04 to $19.69, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,995 shares acquired on May 15, 2019 pursuant to Issuer's employee stock purchase plan."}],"balance_after":12180,"source":{"system":"sec-edgar","filing":"0000899243-19-017621","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319017621/doc4.xml","form_type":"4"}},{"id":3580991,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-03-22T16:05:42.000Z","date":"2019-03-20","kind":"sale","acquired":false,"shares":3000,"price":14.9207,"value":44762.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $14.91 to $14.94, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":13185,"source":{"system":"sec-edgar","filing":"0000899243-19-008784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319008784/doc4.xml","form_type":"4"}},{"id":3695464,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option\n(Right to Buy)","published_at":"2019-01-15T16:06:55.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":126000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from\nJanuary 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":126000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":126000},"source":{"system":"sec-edgar","filing":"0000899243-19-001203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319001203/doc4.xml","form_type":"4"}},{"id":3695463,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-01-15T16:06:55.000Z","date":"2019-01-11","kind":"tax_withholding","acquired":false,"shares":6297,"price":12.37,"value":77893.89,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,278 shares acquired on November 15, 2018, pursuant to Issuer's employee stock purchase plan."}],"balance_after":16185,"source":{"system":"sec-edgar","filing":"0000899243-19-001203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319001203/doc4.xml","form_type":"4"}},{"id":3695462,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-01-15T16:06:55.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":16685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,278 shares acquired on November 15, 2018, pursuant to Issuer's employee stock purchase plan."}],"balance_after":22482,"source":{"system":"sec-edgar","filing":"0000899243-19-001203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924319001203/doc4.xml","form_type":"4"}},{"id":3808162,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-25T16:05:27.000Z","date":"2018-09-21","kind":"exercise","acquired":false,"shares":740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":111741,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":740},"source":{"system":"sec-edgar","filing":"0000899243-18-025185","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924318025185/doc4.xml","form_type":"4"}},{"id":3808161,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-09-25T16:05:27.000Z","date":"2018-09-21","kind":"exercise","acquired":true,"shares":740,"price":13.5,"value":9990.0,"ownership":{"direct":true},"balance_after":4519,"source":{"system":"sec-edgar","filing":"0000899243-18-025185","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924318025185/doc4.xml","form_type":"4"}},{"id":3861451,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-07-25T16:05:38.000Z","date":"2018-07-23","kind":"sale","acquired":false,"shares":9291,"price":18.5633,"value":172471.6203,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $18.20 to $18.93, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,112 shares acquired on May 15, 2018 pursuant to Issuer's employee stock purchase plan."}],"balance_after":3779,"source":{"system":"sec-edgar","filing":"0000899243-18-020572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924318020572/doc4.xml","form_type":"4"}},{"id":4076174,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T16:05:54.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":130000,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0000899243-18-002885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924318002885/doc4.xml","form_type":"4"}},{"id":4126298,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-12-19T16:05:44.000Z","date":"2017-12-15","kind":"grant","acquired":true,"shares":6966,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9958,"source":{"system":"sec-edgar","filing":"0000899243-17-029149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924317029149/doc4.xml","form_type":"4"}},{"id":4240012,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-08-08T16:05:47.000Z","date":"2017-08-06","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to (i) fifty percent (50%) of the total number of shares subject to the option after one year measured from August 1, 2017 (the \"Vesting Commencement Date\"), (ii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the eighteen (18) month anniversary of the Vesting Commencement Date and (iii) an additional twenty-five percent (25%) of the total number of shares subject to the option on the two year anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":67000,"derivative":{"exercise_price":12.7,"expiration_date":"2027-08-06","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0000899243-17-019841","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924317019841/doc4.xml","form_type":"4"}},{"id":4479157,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-27T16:06:07.000Z","date":"2017-01-25","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":112481,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0000899243-17-002094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924317002094/doc4.xml","form_type":"4"}},{"id":4479156,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-01-27T16:06:07.000Z","date":"2017-01-25","kind":"sale","acquired":false,"shares":3900,"price":27,"value":105300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."}],"balance_after":2992,"source":{"system":"sec-edgar","filing":"0000899243-17-002094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924317002094/doc4.xml","form_type":"4"}},{"id":4479155,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-01-27T16:06:07.000Z","date":"2017-01-25","kind":"exercise","acquired":true,"shares":3900,"price":13.5,"value":52650.0,"ownership":{"direct":true},"balance_after":6892,"source":{"system":"sec-edgar","filing":"0000899243-17-002094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924317002094/doc4.xml","form_type":"4"}},{"id":4515293,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-20T16:05:35.000Z","date":"2016-12-19","kind":"exercise","acquired":false,"shares":667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":116381,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":667},"source":{"system":"sec-edgar","filing":"0000899243-16-036028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316036028/doc4.xml","form_type":"4"}},{"id":4515292,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-20T16:05:35.000Z","date":"2016-12-16","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":117048,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0000899243-16-036028","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316036028/doc4.xml","form_type":"4"}},{"id":4515291,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-20T16:05:35.000Z","date":"2016-12-19","kind":"exercise","acquired":true,"shares":667,"price":13.5,"value":9004.5,"ownership":{"direct":true},"balance_after":2992,"source":{"system":"sec-edgar","filing":"0000899243-16-036028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316036028/doc4.xml","form_type":"4"}},{"id":4515290,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-20T16:05:35.000Z","date":"2016-12-16","kind":"sale","acquired":false,"shares":3900,"price":28.2987,"value":110364.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.75 to $28.70, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2325,"source":{"system":"sec-edgar","filing":"0000899243-16-036028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316036028/doc4.xml","form_type":"4"}},{"id":4515289,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-20T16:05:35.000Z","date":"2016-12-16","kind":"exercise","acquired":true,"shares":3900,"price":13.5,"value":52650.0,"ownership":{"direct":true},"balance_after":6225,"source":{"system":"sec-edgar","filing":"0000899243-16-036028","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316036028/doc4.xml","form_type":"4"}},{"id":4544883,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-11-22T16:05:34.000Z","date":"2016-11-18","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":120948,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0000899243-16-034104","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316034104/doc4.xml","form_type":"4"}},{"id":4544882,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-22T16:05:34.000Z","date":"2016-11-18","kind":"sale","acquired":false,"shares":3900,"price":28.1936,"value":109955.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $27.95 to $28.40, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2325,"source":{"system":"sec-edgar","filing":"0000899243-16-034104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316034104/doc4.xml","form_type":"4"}},{"id":4544881,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-11-22T16:05:34.000Z","date":"2016-11-18","kind":"exercise","acquired":true,"shares":3900,"price":13.5,"value":52650.0,"ownership":{"direct":true},"balance_after":6225,"source":{"system":"sec-edgar","filing":"0000899243-16-034104","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316034104/doc4.xml","form_type":"4"}},{"id":4574784,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-25T16:05:23.000Z","date":"2016-10-21","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":124848,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0000899243-16-032269","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316032269/doc4.xml","form_type":"4"}},{"id":4574783,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-10-25T16:05:23.000Z","date":"2016-10-21","kind":"sale","acquired":false,"shares":3900,"price":30.6161,"value":119402.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.93 to $30.89, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2325,"source":{"system":"sec-edgar","filing":"0000899243-16-032269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316032269/doc4.xml","form_type":"4"}},{"id":4574782,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-10-25T16:05:23.000Z","date":"2016-10-21","kind":"exercise","acquired":true,"shares":3900,"price":13.5,"value":52650.0,"ownership":{"direct":true},"balance_after":6225,"source":{"system":"sec-edgar","filing":"0000899243-16-032269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316032269/doc4.xml","form_type":"4"}},{"id":4593230,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-28T16:05:25.000Z","date":"2016-09-26","kind":"exercise","acquired":false,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares vest pursuant to the following schedule:  Twenty Five  Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the \"Vesting Commencement Date\") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":128748,"derivative":{"exercise_price":13.5,"expiration_date":"2024-11-05","underlying":"Common Stock","underlying_shares":3900},"source":{"system":"sec-edgar","filing":"0000899243-16-030224","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316030224/doc4.xml","form_type":"4"}},{"id":4593229,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-09-28T16:05:25.000Z","date":"2016-09-26","kind":"sale","acquired":false,"shares":3900,"price":29.8846,"value":116549.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction was executed in multiple trades in prices ranging from $29.59 to $30.18, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2325,"source":{"system":"sec-edgar","filing":"0000899243-16-030224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316030224/doc4.xml","form_type":"4"}},{"id":4593228,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":67211,"kind":"person","name":"Viret Jean-Frederic","position":1,"cik":"0001427569","reported_name":"Viret Jean-Frederic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-09-28T16:05:25.000Z","date":"2016-09-26","kind":"exercise","acquired":true,"shares":3900,"price":13.5,"value":52650.0,"ownership":{"direct":true},"balance_after":6225,"source":{"system":"sec-edgar","filing":"0000899243-16-030224","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1427569/000089924316030224/doc4.xml","form_type":"4"}}]}